Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to thousands of Brits as soon as next month ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer earlier. This tool may help guide treatment, such as signalling when to ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...